CUP-AI-Dx: A tool for inferring cancer tissue of origin and molecular subtype using RNA gene-expression data and artificial intelligence

Yue Zhao(Jackson Laboratory), Joshy George(Jackson Laboratory), Carolyn Paisie(Jackson Laboratory), Andrew Pattison(University of Melbourne), Anthony J. Gill(The University of Sydney), Kanwal Raghav(The University of Texas MD Anderson Cancer Center), Atara Posner(The University of Melbourne), Sandeep Namburi(Jackson Laboratory), Jens Rueter(Jackson Laboratory), William F. Flynn(Jackson Laboratory), Ziwei Pan(Ministry of Public Health), Honey V. Reddi(The JAX Cancer Center), Richard W. Tothill(The University of Melbourne), Stephen B. Fox(Peter MacCallum Cancer Centre), Sheng Li(Jackson Laboratory), Shiva Balachander(University of Melbourne), R. Krishna Murthy Karuturi(Jackson Laboratory)
EBioMedicine
October 9, 2020
10.1016/j.ebiom.2020.103030
Cited by 134

Related Papers

<i>BRCA</i> Mutation Frequency and Patterns of Treatment Response in <i>BRCA</i> Mutation–Positive Women With Ovarian Cancer: A Report From the Australian Ovarian Cancer Study Group
|Journal of Clinical Oncology|2012|1.2k
Activating ESR1 mutations in hormone-resistant metastatic breast cancer
|Nature Genetics|2013|1.2k
The 2019 World Health Organization classification of tumours of the breast
|Histopathology|2020|1.1k
Assessing Tumor-Infiltrating Lymphocytes in Solid Tumors: A Practical Review for Pathologists and Proposal for a Standardized Method from the International Immuno-Oncology Biomarkers Working Group: Part 2: TILs in Melanoma, Gastrointestinal Tract Carcinomas, Non–Small Cell Lung Carcinoma and Mesothelioma, Endometrial and Ovarian Carcinomas, Squamous Cell Carcinoma of the Head and Neck, Genitourinary Carcinomas, and Primary Brain Tumors
|Advances in Anatomic Pathology|2017|795
Prognostic Significance of p16 <sup>INK4A</sup> and Human Papillomavirus in Patients With Oropharyngeal Cancer Treated on TROG 02.02 Phase III Trial
|Journal of Clinical Oncology|2010|741